TITAN PHARMACEUTICAL (TTP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BRAVEHEART who wrote (62)	5/18/1999 9:19:00 AM
From: scaram(o)uche	Read Replies (1) of 362

status update on Pivanex and CeaVac....... biz.yahoo.com Titan's third anti-cancer vaccine, CeaVac(tm), is being tested in a 200 patient multi-center, placebo controlled, randomized Phase II study in the U.S. and the U.K. for treatment of metastatic colorectal cancer. Titan is also developing Pivanex(tm), an analog of butyric acid, which attacks cancer cells through the mechanism of cellular differentiation. In Phase I testing, Pivanex demonstrated anti-tumor activity in a patient with squamous cell lung cancer, and also demonstrated possible stabilization of disease, with improved performance status, in a patient with thymoma refractory to multiple therapies. Based on these encouraging results, Titan is conducting a Phase II study with Pivanex in non-small cell lung cancer patients.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next